Lumenis

acquiredseries-c-plus
series-c-plus
Stage
3
Investors

About

A global leader in the field of minimally-invasive clinical solutions for the Aesthetic & Ophthalmology markets. World-renowned expert in developing & commercializing innovative energy-based technologies, including CO2, Intense Pulsed Light (IPL) & Radio-Frequency (RF) devices.

Explore Lumenis's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.